CRISPR/Cas9-mediated multiple single guide RNAs potently abrogate pseudorabies virus replication

被引:32
|
作者
Tang, Yan-Dong [1 ]
Liu, Ji-Ting [1 ]
Wang, Tong-Yun [1 ]
Sun, Ming-Xia [1 ]
Tian, Zhi-Jun [1 ]
Cai, Xue-Hui [1 ]
机构
[1] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, 678 HaPing Rd, Harbin 150069, Heilongjiang, Peoples R China
关键词
CRISPR/Cas9; Pseudorabies virus; Inhibition; SgRNA; INHIBIT HIV-1 REPLICATION; GENOMIC CHARACTERIZATION; CELLS; CHINA; GENE; ENDONUCLEASE; VARIANT; ESCAPE; INFECTION; STRATEGY;
D O I
10.1007/s00705-017-3553-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudorabies virus (PRV) is a swine herpesvirus that causes significant morbidity and mortality in swine populations and has caused huge economic losses in the worldwide swine industry. Currently, there is no effective antiviral drug in clinical use for PRV infection; it is also difficult to eliminate PRV from infected swine. In our study, we set out to combat these swine herpesvirus infections by exploiting the CRISPR/Cas9 system. We designed 75 single guide RNAs (sgRNA) by targeting both essential and non-essential genes across the genome of PRV. We applied a firefly luciferase-tagged reporter PRV virus for high-throughput sgRNA screening and found that most of the sgRNAs significantly inhibited PRV replication. More importantly, using a transfection assay, we demonstrated that simultaneous targeting of PRV with multiple sgRNAs completely abolished the production of infectious viruses in cells. These data suggest that CRISPR/Cas9 could be a novel therapeutic agent against PRV in the future.
引用
收藏
页码:3881 / 3886
页数:6
相关论文
共 50 条
  • [31] Acceleration of CRISPR/Cas9-Mediated Editing at Multiple Sites in the Saccharomyces cerevisiae Genome
    Karpukhin, Alexey D. D.
    Sabirzyanov, Fanis A. A.
    Serebrianyi, Vsevolod A. A.
    METHODS AND PROTOCOLS, 2023, 6 (02)
  • [32] CRISPR/Cas9-Mediated Knockout of the HuR Gene in U251 Cell Inhibits Japanese Encephalitis Virus Replication
    Luo, Sai-Qi
    Cao, San-Jie
    Zhao, Qin
    MICROORGANISMS, 2024, 12 (02)
  • [33] CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy
    Ding, Shuai
    Liu, Jinfeng
    Han, Xin
    Tang, Mengfan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [34] CRISPR/Cas9-mediated genome editing in nonhuman primates
    Kang, Yu
    Chu, Chu
    Wang, Fang
    Niu, Yuyu
    DISEASE MODELS & MECHANISMS, 2019, 12 (10)
  • [35] CRISPR/Cas9-mediated correction of human genetic disease
    Men, Ke
    Duan, Xingmei
    He, Zhiyao
    Yang, Yang
    Yao, Shaohua
    Wei, Yuquan
    SCIENCE CHINA-LIFE SCIENCES, 2017, 60 (05) : 447 - 457
  • [36] CRISPR/Cas9-mediated genome editing in sea urchins
    Lin, Che-Yi
    Oulhen, Nathalie
    Wessel, Gary
    Su, Yi-Hsien
    ECHINODERMS, PT B, 2019, 151 : 305 - 321
  • [37] Potential pitfalls of CRISPR/Cas9-mediated genome editing
    Peng, Rongxue
    Lin, Guigao
    Li, Jinming
    FEBS JOURNAL, 2016, 283 (07) : 1218 - 1231
  • [38] CRISPR–Cas9-mediated genome editing in apple and grapevine
    Yuriko Osakabe
    Zhenchang Liang
    Chong Ren
    Chikako Nishitani
    Keishi Osakabe
    Masato Wada
    Sadao Komori
    Mickael Malnoy
    Riccardo Velasco
    Michele Poli
    Min-Hee Jung
    Ok-Jae Koo
    Roberto Viola
    Chidananda Nagamangala Kanchiswamy
    Nature Protocols, 2018, 13 : 2844 - 2863
  • [39] CRISPR/Cas9-mediated genome editing in Hevea brasiliensis
    Dai, Xuemei
    Yang, Xianfeng
    Wang, Chun
    Fan, Yueting
    Xin, Shichao
    Hua, Yuwei
    Wang, Kejian
    Huang, Huasun
    INDUSTRIAL CROPS AND PRODUCTS, 2021, 164
  • [40] CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells
    Wen, Luan
    Zhao, Changzhi
    Song, Jun
    Ma, Linyuan
    Ruan, Jinxue
    Xia, Xiaofeng
    Chen, Y. Eugene
    Zhang, Jifeng
    Ma, Peter X.
    Xu, Jie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (02)